81 – 90 of 236
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.
(
- Contribution to journal › Article
-
Mark
The interface of population-based cancer registries and biobanks in etiological and clinical research - current and future perspectives.
(
- Contribution to journal › Article
-
Mark
Three novel papillomaviruses (HPV109, HPV112 and HPV114) and their presence in cutaneous and mucosal samples.
(
- Contribution to journal › Article
-
Mark
Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women.
(
- Contribution to journal › Article
- 2009
-
Mark
Introduction of human papillomavirus (HPV) vaccination in Sweden
(
- Contribution to journal › Article
-
Mark
Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection
(
- Contribution to journal › Article
-
Mark
Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.
(
- Contribution to journal › Article
-
Mark
Risk of invasive cervical cancer in relation to management of abnormal Pap smear results
(
- Contribution to journal › Article
-
Mark
A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions
(
- Contribution to journal › Article
-
Mark
Is Smoking an Independent Risk Factor for Invasive Cervical Cancer? A Nested Case-Control Study Within Nordic Biobanks
(
- Contribution to journal › Article